Venus Concept Inc. (NASDAQ:VERO) Short Interest Update

Venus Concept Inc. (NASDAQ:VERO) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 27,700 shares, a growth of 114.7% from the March 15th total of 12,900 shares. Based on an average daily volume of 538,100 shares, the short-interest ratio is presently 0.1 days. Approximately 0.7% of the shares of the company are short sold.

Venus Concept Price Performance

VERO stock opened at $0.69 on Thursday. Venus Concept has a fifty-two week low of $0.60 and a fifty-two week high of $4.70. The firm’s 50-day simple moving average is $0.92 and its 200 day simple moving average is $1.36. The stock has a market cap of $4.39 million, a PE ratio of -0.10 and a beta of 0.66.

Institutional Trading of Venus Concept

A number of large investors have recently modified their holdings of the company. Vanguard Group Inc. increased its holdings in shares of Venus Concept by 2.3% in the 1st quarter. Vanguard Group Inc. now owns 1,121,558 shares of the company’s stock worth $1,603,000 after acquiring an additional 25,630 shares during the period. Commonwealth Equity Services LLC increased its holdings in shares of Venus Concept by 1,762.1% in the 1st quarter. Commonwealth Equity Services LLC now owns 186,208 shares of the company’s stock worth $40,000 after acquiring an additional 176,208 shares during the period. Prelude Capital Management LLC increased its holdings in shares of Venus Concept by 73.4% in the 1st quarter. Prelude Capital Management LLC now owns 177,246 shares of the company’s stock worth $253,000 after acquiring an additional 75,000 shares during the period. SVB Financial Group acquired a new stake in shares of Venus Concept in the 4th quarter worth about $51,000. Finally, Bank of New York Mellon Corp increased its holdings in shares of Venus Concept by 140.2% in the 1st quarter. Bank of New York Mellon Corp now owns 86,578 shares of the company’s stock worth $124,000 after acquiring an additional 50,530 shares during the period. Institutional investors and hedge funds own 87.41% of the company’s stock.

About Venus Concept

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.